Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry

Antonio Vitale, Valeria Caggiano, Flavia Leone, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, Guillermo Arturo Guaracha-Basañez, Jiram Torres-Ruiz, Perla Ayumi Kawakami-Campos, Pravin Hissaria, Alicia Callisto, Mark Beecher, Lorenzo Dagna, Corrado Campochiaro, Alessandro Tomelleri, Micol Frassi, Franco Franceschini, Francesca Crisafulli, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Olga Araújo, Paolo Sfriso, Sara Bindoli, Chiara Baggio, Jurgen Sota, Abdurrahman Tufan, Hamit Kucuk, Matteo Piga, Alberto Cauli, Maria Antonietta D’Agostino, Amato De Paulis, Ilaria Mormile, Henrique A. Mayrink Giardini, Rafael Alves Cordeiro, Giuseppe Lopalco, Florenzo Iannone, Sara Monti, Carlomaurizio Montecucco, Guillermo Ruiz-Irastorza, Adriana Soto-Peleteiro, Paola Triggianese, Carmelo Gurnari, Ombretta Viapiana, Riccardo Bixio, Rosetta Vitetta, Guido Rovera, Edoardo Conticini, Francesco La Torre, Piero Portincasa, Nour Jaber, Gaafar Ragab, Amina Maher, Ezgi Deniz Batu, Seza Ozen, Ewa Wiesik-Szewczyk, Alejandra de-la-Torre, Alberto Balistreri, Bruno Frediani, Claudia Fabiani, Luca Cantarini

Open source

DOI
10.3389/fphar.2025.1462254
Published
2025-02-19
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1462254,
  title = {Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry},
  author = {Antonio Vitale and Valeria Caggiano and Flavia Leone and Andrea Hinojosa-Azaola and Eduardo Martín-Nares and Guillermo Arturo Guaracha-Basañez and Jiram Torres-Ruiz and Perla Ayumi Kawakami-Campos and Pravin Hissaria and Alicia Callisto and Mark Beecher and Lorenzo Dagna and Corrado Campochiaro and Alessandro Tomelleri and Micol Frassi and Franco Franceschini and Francesca Crisafulli and José Hernández-Rodríguez and Verónica Gómez-Caverzaschi and Olga Araújo and Paolo Sfriso and Sara Bindoli and Chiara Baggio and Jurgen Sota and Abdurrahman Tufan and Hamit Kucuk and Matteo Piga and Alberto Cauli and Maria Antonietta D’Agostino and Amato De Paulis and Ilaria Mormile and Henrique A. Mayrink Giardini and Rafael Alves Cordeiro and Giuseppe Lopalco and Florenzo Iannone and Sara Monti and Carlomaurizio Montecucco and Guillermo Ruiz-Irastorza and Adriana Soto-Peleteiro and Paola Triggianese and Carmelo Gurnari and Ombretta Viapiana and Riccardo Bixio and Rosetta Vitetta and Guido Rovera and Edoardo Conticini and Francesco La Torre and Piero Portincasa and Nour Jaber and Gaafar Ragab and Amina Maher and Ezgi Deniz Batu and Seza Ozen and Ewa Wiesik-Szewczyk and Alejandra de-la-Torre and Alberto Balistreri and Bruno Frediani and Claudia Fabiani and Luca Cantarini},
  year = {2025},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2025.1462254},
  url = {https://doi.org/10.3389/fphar.2025.1462254}
}

RIS

TY  - JOUR
TI  - Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry
AU  - Antonio Vitale
AU  - Valeria Caggiano
AU  - Flavia Leone
AU  - Andrea Hinojosa-Azaola
AU  - Eduardo Martín-Nares
AU  - Guillermo Arturo Guaracha-Basañez
AU  - Jiram Torres-Ruiz
AU  - Perla Ayumi Kawakami-Campos
AU  - Pravin Hissaria
AU  - Alicia Callisto
AU  - Mark Beecher
AU  - Lorenzo Dagna
AU  - Corrado Campochiaro
AU  - Alessandro Tomelleri
AU  - Micol Frassi
AU  - Franco Franceschini
AU  - Francesca Crisafulli
AU  - José Hernández-Rodríguez
AU  - Verónica Gómez-Caverzaschi
AU  - Olga Araújo
AU  - Paolo Sfriso
AU  - Sara Bindoli
AU  - Chiara Baggio
AU  - Jurgen Sota
AU  - Abdurrahman Tufan
AU  - Hamit Kucuk
AU  - Matteo Piga
AU  - Alberto Cauli
AU  - Maria Antonietta D’Agostino
AU  - Amato De Paulis
AU  - Ilaria Mormile
AU  - Henrique A. Mayrink Giardini
AU  - Rafael Alves Cordeiro
AU  - Giuseppe Lopalco
AU  - Florenzo Iannone
AU  - Sara Monti
AU  - Carlomaurizio Montecucco
AU  - Guillermo Ruiz-Irastorza
AU  - Adriana Soto-Peleteiro
AU  - Paola Triggianese
AU  - Carmelo Gurnari
AU  - Ombretta Viapiana
AU  - Riccardo Bixio
AU  - Rosetta Vitetta
AU  - Guido Rovera
AU  - Edoardo Conticini
AU  - Francesco La Torre
AU  - Piero Portincasa
AU  - Nour Jaber
AU  - Gaafar Ragab
AU  - Amina Maher
AU  - Ezgi Deniz Batu
AU  - Seza Ozen
AU  - Ewa Wiesik-Szewczyk
AU  - Alejandra de-la-Torre
AU  - Alberto Balistreri
AU  - Bruno Frediani
AU  - Claudia Fabiani
AU  - Luca Cantarini
PY  - 2025
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2025.1462254
UR  - https://doi.org/10.3389/fphar.2025.1462254
ER  -

APA

Vitale, A., Caggiano, V., Leone, F., Hinojosa-Azaola, A., Martín-Nares, E., Guaracha-Basañez, G. A., Torres-Ruiz, J., Kawakami-Campos, P. A., Hissaria, P., Callisto, A., Beecher, M., Dagna, L., Campochiaro, C., Tomelleri, A., Frassi, M., Franceschini, F., Crisafulli, F., Hernández-Rodríguez, J., Gómez-Caverzaschi, V., Araújo, O., Sfriso, P., Bindoli, S., Baggio, C., Sota, J., Tufan, A., Kucuk, H., Piga, M., Cauli, A., D’Agostino, M. A., Paulis, A. D., Mormile, I., Giardini, H. A. M., Cordeiro, R. A., Lopalco, G., Iannone, F., Monti, S., Montecucco, C., Ruiz-Irastorza, G., Soto-Peleteiro, A., Triggianese, P., Gurnari, C., Viapiana, O., Bixio, R., Vitetta, R., Rovera, G., Conticini, E., Torre, F. L., Portincasa, P., Jaber, N., Ragab, G., Maher, A., Batu, E. D., Ozen, S., Wiesik-Szewczyk, E., de-la-Torre, A., Balistreri, A., Frediani, B., Fabiani, C., & Cantarini, L. (2025). Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1462254

Source records